NCT00887029View on ClinicalTrials.gov

A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma

PHASE4CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Open-Angle GlaucomaOcular Hypertension
Interventions
DRUG

DuoTrav (travoprost-timolol ophthalmic drops)

topical ophthalmic drops instilled 1 drop daily

DRUG

Xalacom (latanoprost-timolol ophthalmic drops)

topical ophthalmic drops instilled 1 drop daily

Trial Locations (2)

L4W1W9

Ophthalmic Consultant Centres, Mississauga

M5R2M8

Dr David B. Yan, M.D., F.R.C.S.C., Toronto

Sponsors

Collaborators (1)

Alcon Research
All Listed Sponsors
collaborator

Alcon Research

INDUSTRY

lead

Ophthalmic Consultants Centres, Canada

OTHER

NCT00887029 - A 12 Week Comparison of DuoTrav and Xalacom in Open-Angle Glaucoma | Biotech Hunter | Biotech Hunter